Alejandro A. Rabinstein

Homocysteine Lowering with Folic Acid and B Vitamins in Vascular DiseaseLonn E, for The Heart Outcomes Prevention Evaluation (HOPE) 2 Investigators (McMaster Univ, Hamilton, Ont, Canada; et al) N Engl J Med 354:1567–1577, 2006§

Discontinuing Prophylactic Transfusions Used to Prevent Stroke in Sickle Cell Disease

Perfusion Computed Tomography: Prediction of Final Infarct Extent and Stroke OutcomeParsons MW, Pepper EM, Chan V, et al (Univ of Newcastle, New South Wales, Australia) Ann Neurol 58:672–679, 2005§

The ALIAS Pilot Trial: A Dose-Escalation and Safety Study of Albumin Therapy for Acute Ischemic Stroke—I: Physiological Responses and Safety ResultsGinsberg MD, Hill MD, Palesch YY, et al (Univ of Miami, Fla; Univ of Calgary, Alta, Canada; Med Univ of South Carolina, Charleston) Stroke 37:2100–2106, 2006§

Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentre randomised controlled trialDahlöf B, for the ASCOT Investigators (Sahlgrenska Univ, Göteborg, Sweden; et al) Lancet 366:895–906, 2005§

Good Outcomes in Ischemic Stroke Patients Treated with Intravenous Thrombolysis Despite Regressing Neurological SymptomsBaumann CR, Baumgartner RW, Gandjour J, et al (Univ of Zürich, Switzerland) Stroke 37:1332–1333, 2006§

Discontinuing Prophylactic Transfusions Used to Prevent Stroke in Sickle Cell DiseaseAdams RJ, for The Optimizing Primary Stroke Prevention in Sickle Cell Anemia (STOP 2) Trial Investigators (Med College of Georgia, Augusta; Med Univ of South Carolina, Charleston; Univ of Miami, Fla; et al) N Engl J Med 353:2769–2778, 2005§

Clopidogrel and Aspirin versus Aspirin Alone for the Prevention of Atherothrombotic EventsTopol EJ, for the CHARISMA Investigators (Case Western Reserve Univ, Cleveland, Ohio; et al) N Engl J Med 354:1–12, 2006§

Clinical Outcome After First and Recurrent Hemorrhage in Patients With Untreated Brain Arteriovenous MalformationChoi JH, Mast H, Sciacca RR, et al (Columbia Univ, New York; Ernst Moritz Arndt Univ, Greifswald, Germany; Hôpital Lariboistière, Paris; et al) Stroke 37:1243–1247, 2006§

Efficacy and safety of cholesterol-lowering treatment: prospective metaanalysis of data from 90 056 participants in 14 randomised trials of statinsCholesterol Treatment Trialists' (CTT) Collaborators (Clinical Trial Service Unit and Epidemiological Studies Unit, Oxford, England; et al) Lancet 366:1267–1278, 2005§